V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009872 | 330003938 | 1.67 | 123 | Curative (C) | 2017-07-04 | 2017-07-25 | Trial Unspecified | N | N | 330007962 | TRIAL |
| 330009873 | 330003938 | 1.77 | 86.8 | null | null | 2016-11-17 | DOXORUBICIN | N | null | 330007962 | DOXORUBICIN |
| 330009874 | 330003940 | 1.6 | 67.4 | Curative (C) | 2014-07-22 | 2014-07-22 | Doxorubicin 75mg/m2 | N | N | 330007971 | DOXORUBICIN |
| 330009876 | 330003948 | 1.76 | 88.4 | Curative (C) | 2014-07-29 | 2014-07-31 | PAM | N | Y | 330007988 | MAP |
| 330009877 | 330003950 | 1.81 | 87.3 | Curative (C) | 2014-12-25 | 2014-12-26 | Etoposide + Ifosfamide (3 days) | 2 | null | 330007993 | ETOPOSIDE + IFOSFAMIDE |
| 330009878 | 330008147 | 1.55 | null | Curative (C) | 2017-01-25 | 2017-01-25 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008007 | ETOPOSIDE + IFOSFAMIDE |
| 330009879 | 330003952 | 1.55 | 57 | Curative (C) | 2017-01-15 | 2017-01-15 | CARBOPLATIN | null | null | 330008009 | CARBOPLATIN |
| 330009880 | 330010421 | 1.76 | null | Curative (C) | 2013-04-19 | 2013-04-27 | Etoposide + Ifosfamide (3 days) | Y | Y | 330008011 | ETOPOSIDE + IFOSFAMIDE |
| 330009881 | 330003953 | null | 51.2 | Curative (C) | 2016-07-13 | 2016-07-17 | Methotrexate High Dose (3g/m2) | Y | N | 330008012 | METHOTREXATE HIGH DOSE |
| 330009882 | 330003954 | 1.77 | 88 | Curative (C) | null | 2015-12-09 | Carboplatin AUC 6 - 10 | null | null | 330008035 | CARBOPLATIN |
| 330009883 | 330003954 | null | 112.3 | Curative (C) | 2016-09-10 | 2016-09-17 | Carboplatin AUC 6 - 10 | N | N | 330008035 | CARBOPLATIN |
| 330009884 | 330003959 | 1.68 | 0 | Palliative (P) | 2013-09-18 | 2014-02-26 | Cetuximab 7 day (>Cycle 2) | N | null | 330008047 | CETUXIMAB |
| 330009885 | 330008153 | 0 | 42.7 | Adjuvant (A) | 2018-10-30 | 2018-11-13 | CARBOPLATIN | null | N | 330008049 | CARBOPLATIN |
| 330009886 | 330003962 | 0 | 107 | Neo-adjuvant (N) | 2014-10-20 | 2014-10-23 | Methotrexate High Dose (3g/m2) | Y | null | 330008050 | METHOTREXATE HIGH DOSE |
| 330009887 | 330003963 | 1.79 | 47.9 | Curative (C) | 2016-12-10 | 2016-12-11 | MAP | Y | N | 330008053 | MAP |
| 330009888 | 330010427 | 0 | 52.3 | Palliative (P) | null | 2015-10-27 | Carboplatin AUC 2 - 5 | N | N | 330008059 | CARBOPLATIN |
| 330009889 | 330003964 | 1.63 | 51.3 | Neo-adjuvant (N) | 2013-11-01 | 2013-11-01 | CISPLATIN + FLUOROURACIL | N | N | 330008065 | CISPLATIN + FLUOROURACIL |
| 330009890 | 330010428 | 1.7 | 82.4 | Curative (C) | 2017-05-12 | 2017-05-12 | PAM x 2 post-surgery (cycles 3&4) | Y | Y | 330008066 | MAP |
| 330009891 | 330008158 | 1.91 | 47.9 | Palliative (P) | 2013-06-29 | 2013-07-17 | Docetaxel + Gemcitabine (prior RT) | Y | N | 330008073 | DOCETAXEL + GEMCITABINE |
| 330009892 | 330003966 | 1.68 | 54.3 | Curative (C) | 2015-01-16 | 2015-01-16 | CISPLATIN + FLUOROURACIL | N | N | 330008090 | CISPLATIN + FLUOROURACIL |
| 330009893 | 330003968 | 1.58 | 38.4 | Palliative (P) | 2014-10-12 | 2015-01-28 | CISPLATIN + FLUOROURACIL | N | N | 330008095 | CISPLATIN + FLUOROURACIL |
| 330009894 | 330003970 | 1.7 | 62.7 | Neo-adjuvant (N) | 2012-12-26 | 2013-02-08 | Etoposide + Ifosfamide (5 days) | 02 | N | 330008102 | ETOPOSIDE + IFOSFAMIDE |
| 330009895 | 330003973 | 1.68 | 82 | Curative (C) | 2017-02-05 | 2017-03-02 | CISPLATIN + FLUOROURACIL | 02 | N | 330008116 | CISPLATIN + FLUOROURACIL |
| 330009897 | 330003977 | 1.66 | 59.6 | Adjuvant (A) | 2013-09-03 | 2013-12-11 | PAM x 2 post-surgery (cycles 3&4) | Y | N | 330008124 | MAP |
| 330009898 | 330003980 | 1.8 | 106.5 | Neo-adjuvant (N) | 2017-12-07 | 2018-02-22 | Etoposide + Ifosfamide (3 days) | 2 | N | 330008126 | ETOPOSIDE + IFOSFAMIDE |
| 330009899 | 330003982 | 1.83 | 70.8 | Curative (C) | null | 2013-12-18 | Rituximab | N | N | 330008129 | RITUXIMAB |
| 330009900 | 330011688 | 1.66 | 63 | Neo-adjuvant (N) | 2014-06-09 | 2014-06-09 | Etoposide + Ifosfamide (5 days) | 02 | N | 330008132 | ETOPOSIDE + IFOSFAMIDE |
| 330009901 | 330003983 | 1.79 | 103 | Adjuvant (A) | 2016-08-18 | 2016-08-18 | OST Euramos 1 Closed Trial - M | N | N | 330008133 | METHOTREXATE HIGH DOSE |
| 330009902 | 330003984 | null | 72.3 | Curative (C) | 2017-12-04 | 2017-12-04 | CARBOPLATIN | 02 | N | 330008137 | CARBOPLATIN |
| 330009903 | 330011689 | 1.53 | 51.3 | Neo-adjuvant (N) | 2014-01-23 | 2014-03-02 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008138 | MAP |
| 330009904 | 330008172 | 1.57 | 65 | Not known (9) | 2014-04-25 | 2014-04-27 | OST Euramos 1 Closed Trial - AP | 2 | N | 330008146 | MAP |
| 330009905 | 330003989 | 1.6 | null | Palliative (P) | 2013-08-22 | 2013-08-23 | CETUXIMAB | Y | N | 330008147 | CETUXIMAB |
| 330009906 | 330003991 | 1.67 | 60.5 | Adjuvant (A) | 2013-12-28 | 2014-01-30 | OST Euramos 1 Closed Trial - M | N | N | 330008152 | METHOTREXATE HIGH DOSE |
| 330009907 | 330010439 | 1.59 | 52 | Disease modification (D) | 2012-12-31 | 2013-05-19 | Rituximab (Maintenance) | N | N | 330008160 | RITUXIMAB |
| 330009908 | 330003994 | 1.68 | 68 | Curative (C) | null | 2015-02-01 | CARBOPLATIN | 02 | null | 330008177 | CARBOPLATIN |
| 330009909 | 330003996 | 0 | 47.4 | null | 2016-04-26 | 2016-05-11 | Carboplatin AUC 2 - 5 | 02 | N | 330008190 | CARBOPLATIN |
| 330009910 | 330008179 | 1.71 | 83.6 | Palliative (P) | 2015-10-02 | 2015-12-21 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008194 | MAP |
| 330009911 | 330008182 | 1.6 | 54.6 | Palliative (P) | 2016-08-31 | 2016-09-05 | Etoposide + Ifosfamide (3 days) | 02 | Y | 330008198 | ETOPOSIDE + IFOSFAMIDE |
| 330009912 | 330004008 | 1.75 | null | Palliative (P) | 2014-04-27 | 2014-08-04 | Rituximab | 02 | N | 330008208 | RITUXIMAB |
| 330009913 | 330004010 | 1.73 | 87.9 | Palliative (P) | 2013-10-27 | 2013-10-27 | Etoposide + Ifosfamide (3 days) | 02 | null | 330008219 | ETOPOSIDE + IFOSFAMIDE |
| 330009914 | 330004014 | null | 128 | Palliative (P) | 2017-04-24 | 2017-04-24 | Cetuximab 7 day (>Cycle 2) | 02 | null | 330008235 | CETUXIMAB |
| 330009915 | 330004017 | 1.69 | null | Palliative (P) | 2015-11-13 | 2016-01-07 | DOCETAXEL + GEMCITABINE | N | N | 330008235 | DOCETAXEL + GEMCITABINE |
| 330009916 | 330004017 | 1.58 | null | Curative (C) | null | 2016-12-25 | Carboplatin AUC 2 - 5 | 2 | N | 330008235 | CARBOPLATIN |
| 330009917 | 330004019 | 1.83 | 65.5 | null | 2017-03-10 | 2017-05-05 | MAP | 2 | N | 330008263 | MAP |
| 330009918 | 330004022 | 1.64 | 43.5 | Palliative (P) | 2017-06-25 | 2017-07-23 | Cetuximab 7 day (>Cycle 2) | 02 | N | 330008266 | CETUXIMAB |
| 330009919 | 330004024 | null | 95 | Palliative (P) | 2015-12-01 | 2015-12-12 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008268 | ETOPOSIDE + IFOSFAMIDE |
| 330009920 | 330004027 | 1.6 | 62.45 | Curative (C) | 2017-03-03 | 2017-03-31 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 330008284 | RITUXIMAB |
| 330009921 | 330004029 | 1.6 | 61.3 | Curative (C) | 2013-11-16 | 2013-12-06 | Carboplatin AUC 6 - 10 | 02 | N | 330008290 | CARBOPLATIN |
| 330009922 | 330004031 | 1.66 | null | null | 2014-10-05 | 2014-10-08 | Cetuximab 7 day (>Cycle 2) | null | null | 330008298 | CETUXIMAB |
| 330009923 | 330004034 | 1.79 | 54 | Palliative (P) | 2016-02-08 | 2016-03-04 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008305 | ETOPOSIDE + IFOSFAMIDE |